MOUNTAIN VIEW, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will present at two upcoming investor conferences: Stifel Healthcare Conference on Tuesday, November 14 at 2:25…Read More
IGM Biosciences to Present at Two Upcoming Investor Conferences
